Ireland
--:--IST
Latest
Clinical Trials in Denmark / NCT06705400
Recruiting Not applicable

The Bloom Study - a Safe and Healthy Start in Life

NCT06705400 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2025-12-22

Condition(s) studied

Overweight, ChildhoodObesity in Children

Investigational drug(s) / intervention(s)

Multi-behavioural

Multi-behavioural: The Bloom Study is implemented in an existing and highly accepted health service delivered by community health nurses. Beyond focusing on food, meals, motor skills and movement, the intervention also target sleep and family sense of security. The intervention commence in pregnancy and continues until the child is 2½ years old.

Study summary

The aim of the Bloom Study is to promote healthy weight development among infants through a home-based health promoting intervention implemented in the Danish setting of community health nurses. The intervention begins during pregnancy and runs until the child reaches the age of 30 months.

The Bloom Intervention was developed over a six-year period from 2017 to 2023 according to the Intervention Mapping approach and based on a co-creation process.

The Bloom Intervention is evaluated in a cluster-randomized trial involving 22 Danish municipalities (11 intervention and 11 control). All children born from first-time mothers over a period of 12 months are invited to participate.

Eligibility

Sex
ALL
Min age
0 Months
Max age
6 Months
Healthy volunteers
Accepted
Inclusion Criteria: All children born from first-time mothers being in gestation week 20 between November 1st 2024 and October 31st 2025. Exclusion Criteria: Not being able to receive digital post.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Institute of Public Health, University of Southern Denmark Copenhagen Denmark Recruiting

More University of Southern Denmark trials in Denmark

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06705400 on ClinicalTrials.gov ↗ ← All trials in Denmark